Ross Agitated Vessel Includes Silicone Heating Blankets

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2014
Volume 38
Issue 10

The Ross VSL-50 is a portable 50-gallon agitated vessel with silicone heating blankets and temperature sensors fabricated in stainless steel 316 and designed for atmospheric operation.

The Ross VSL-50 is a portable 50-gallon agitated vessel with silicone heating blankets and temperature sensors fabricated in stainless steel 316 and designed for atmospheric operation.

The VSL-50’s propeller agitator has a half HP inverter-duty motor and is controlled by a NEMA 4X stainless-steel panel that includes an E-Stop mushroom head, cycle timer, digital heater temperature controller, and a high-temperature alarm.

Ross Agitated Vessels are customizable and can be equipped with sight/charge ports and process connections.

Charles Ross & Son Company
www.mixers.com

Articles in this issue
Ross-856927-1416898025646.jpg
Ross Agitated Vessel Includes Silicone Heating Blankets
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Wechsler_Jill-856790-1416898146268.jpg
Biopharma Manufacturers Respond to Ebola Crisis
Determining Facility Mold Infection
romacokilianktp-856928-1416898023256.jpg
Romaco Kilian's Tablet Press Introduces Continuous Weight Control
GEA-856930-1416898019279.jpg
GEA Pharma Systems Valves Contain Powders
figure1-856883-1417773790013.jpg
Packaging Addresses Cold-Chain Requirements
Fluorination Remains Key Challenge in API Synthesis
Fluorination Remains Key Challenge in API Synthesis
Fette-856929-1416898021360.jpg
Fette Tablet Press Designed for High Production
Marrying Big Data with Personalized Medicine
Marrying Big Data with Personalized Medicine
Morris_marilyn-856679-1416897342957.jpg
Bolstering Graduate Education and Research Programs
Solving Poor Solubility with Amorphous Solid Dispersions
Solving Poor Solubility with Amorphous Solid Dispersions
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
Milmo_Sean-856903-1416898033486.jpg
Harmonizing Marketing Approval of Generic Drugs in Europe
AlphaG-gd-858224-1416895790953.jpg
Meissner's Filtration System Allows Scalability
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Behind the Headlines, Episode 17: Bespoke CRISPR Therapy, Executive Order Fallout, and More
Industry Outlook 2025: European Political Impacts on the Supply Chain
Industry Outlook 2025: European Political Impacts on the Supply Chain
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
Industry Outlook 2025: The Future of Technology in the Biopharma Industry
Industry Outlook 2025: The Future of Technology in the Biopharma Industry
AAPS National Biotechnology Conference 2025: AAV Vector Production
AAPS National Biotechnology Conference 2025: AAV Vector Production
Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
Industry Outlook 2025: Technology as a Supporting Element
Industry Outlook 2025: Technology as a Supporting Element
Industry Outlook 2025: Talent Up for Grabs
Industry Outlook 2025: Talent Up for Grabs
INTERPHEX 2025: Preventing Spills in the Manufacturing Process
INTERPHEX 2025: Preventing Spills in the Manufacturing Process
Related Content
A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
May 29th 2025
Article

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Digital Transformation Strategies: Modernizing Business Processes, digital transformation strategies with an image of a digital roadmap for organizational change See Less | Image credit: ©Johannes – stock.adobe.com

Digital Transformation in Pharmaceutical Manufacturing

Israel Ortíz
May 28th 2025
Article

Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure accurate documentation, and strengthen data integrity.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Gold winners award with three stars | Image Credit: © sergign - stock.adobe.com

ISPE Announces Six 2025 FOYA Category Winners

Patrick Lavery
May 15th 2025
Article

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.

Feb 2, 2020 South San Francisco / CA / USA - Genentech headquarters in Silicon Valley; Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009 | Image Credit: © Sundry Photography - stock.adobe.com

Genentech and Roche Expand US Footprint with New North Carolina Manufacturing Facility

Patrick Lavery
May 13th 2025
Article

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.